Understanding CD8( ) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
Thi HO Nguyen, Amabel CL Tan, Sue D Xiang, Anne Goubier, Kim L Harland, E Bridie Clemens, Magdalena Plebanski, Katherine Kedzierska
CLINICAL & TRANSLATIONAL IMMUNOLOGY | WILEY | Published : 2017
Awarded by Australian National Health and Medical Research Council (NHMRC) Program
HLA-A2.1 transgenic HHD mice were developed by Dr Francois Lemonnier (Pasteur Institute, Paris, France). We thank Matthew Caverley and Paul Thomas for their technical expertise in TCR sequence analysis. This work was supported by PX Biosolutions and by the Australian National Health and Medical Research Council (NHMRC) Program Grant (ID 1071916). KK and MP are supported by the NHMRC Senior Research Fellowships. EBC is supported by the NHMRC Peter Doherty Fellowship.